TY  - GEN
AU  - Etienne,Gabriel
AU  - Dulucq,Stéphanie
AU  - Nicolini,Franck-Emmanuel
AU  - Morisset,Stéphane
AU  - Fort,Marie-Pierre
AU  - Schmitt,Anna
AU  - Etienne,Madeleine
AU  - Hayette,Sandrine
AU  - Lippert,Eric
AU  - Bureau,Caroline
AU  - Tigaud,Isabelle
AU  - Adiko,Didier
AU  - Marit,Gérald
AU  - Reiffers,Josy
AU  - Mahon,François-Xavier
TI  - Achieving deeper molecular response is associated with a better clinical outcome in chronic myeloid leukemia patients on imatinib front-line therapy
SN  - 1592-8721
PY  - 2015///0413
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Benzamides
KW  - Chromosome Aberrations
KW  - Female
KW  - Follow-Up Studies
KW  - Fusion Proteins, bcr-abl
KW  - genetics
KW  - Humans
KW  - Imatinib Mesylate
KW  - Leukemia, Myelogenous, Chronic, BCR-ABL Positive
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Piperazines
KW  - Protein Kinase Inhibitors
KW  - Pyrimidines
KW  - Treatment Outcome
KW  - Young Adult
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.3324/haematol.2013.095158
ER  -